Thomas Stankovich, Chief Financial Officer at ReShape Lifesciences Inc. (RSLS), sold 5,038 shares at $1.13 ($6K) on 2022-04-01, disclosed to the SEC on 2022-04-08.
Open-market sale of $6k RSLS by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| RSLS | SELL | 2023-07-19 | $156 | — | Filing → |
| RSLS | SELL | 2023-07-06 | $746 | — | Filing → |
| RSLS | BUY | 2023-07-06 | $27K | — | Filing → |